[ad_1] Violence and Spread of Disinformation Now Seen as Legitimate Tools for Change NEW YORK, Jan. 19, 2025 /PRNewswire/ — The 2025 Edelman Trust Barometer reveals that economic fears have metastasized into grievance, with six in […]
Tag: Daniel J. Edelman Holdings
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) shows 51 percent reduction in risk of progression to active multiple myeloma for patients with high-risk smoldering multiple myeloma
[ad_1] First and only subcutaneous anti-CD38 therapy demonstrating potential to prevent end-organ damage, and extend progression-free survival and overall survival based on findings from Phase 3 AQUILA study SAN DIEGO, Dec. 8, 2024 /PRNewswire/ — […]
